BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 22411814)

  • 1. Myeloid leukemia factor is a conserved regulator of RUNX transcription factor activity involved in hematopoiesis.
    Bras S; Martin-Lannerée S; Gobert V; Augé B; Breig O; Sanial M; Yamaguchi M; Haenlin M; Plessis A; Waltzer L
    Proc Natl Acad Sci U S A; 2012 Mar; 109(13):4986-91. PubMed ID: 22411814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Drosophila model identifies calpains as modulators of the human leukemogenic fusion protein AML1-ETO.
    Osman D; Gobert V; Ponthan F; Heidenreich O; Haenlin M; Waltzer L
    Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12043-8. PubMed ID: 19581587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of RUNX-induced repression of Notch signaling by MLF and its partner DnaJ-1 during Drosophila hematopoiesis.
    Miller M; Chen A; Gobert V; Augé B; Beau M; Burlet-Schiltz O; Haenlin M; Waltzer L
    PLoS Genet; 2017 Jul; 13(7):e1006932. PubMed ID: 28742844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid leukemia factor: a return ticket from human leukemia to fly hematopoiesis.
    Gobert V; Haenlin M; Waltzer L
    Transcription; 2012; 3(5):250-4. PubMed ID: 22885977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperation between the GATA and RUNX factors Serpent and Lozenge during Drosophila hematopoiesis.
    Waltzer L; Ferjoux G; Bataillé L; Haenlin M
    EMBO J; 2003 Dec; 22(24):6516-25. PubMed ID: 14657024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A GATA/RUNX cis-regulatory module couples Drosophila blood cell commitment and differentiation into crystal cells.
    Ferjoux G; Augé B; Boyer K; Haenlin M; Waltzer L
    Dev Biol; 2007 May; 305(2):726-34. PubMed ID: 17418114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolving embryonic blood cell fate choice in Drosophila: interplay of GCM and RUNX factors.
    Bataillé L; Augé B; Ferjoux G; Haenlin M; Waltzer L
    Development; 2005 Oct; 132(20):4635-44. PubMed ID: 16176949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the oligomerization domain of ETO interferes with RUNX1/ETO oncogenic activity in t(8;21)-positive leukemic cells.
    Wichmann C; Chen L; Heinrich M; Baus D; Pfitzner E; Zörnig M; Ottmann OG; Grez M
    Cancer Res; 2007 Mar; 67(5):2280-9. PubMed ID: 17332359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Hematopoietic Transcription Factors RUNX1 and ERG Prevent AML1-ETO Oncogene Overexpression and Onset of the Apoptosis Program in t(8;21) AMLs.
    Mandoli A; Singh AA; Prange KHM; Tijchon E; Oerlemans M; Dirks R; Ter Huurne M; Wierenga ATJ; Janssen-Megens EM; Berentsen K; Sharifi N; Kim B; Matarese F; Nguyen LN; Hubner NC; Rao NA; van den Akker E; Altucci L; Vellenga E; Stunnenberg HG; Martens JHA
    Cell Rep; 2016 Nov; 17(8):2087-2100. PubMed ID: 27851970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The t(8;21) translocation converts AML1 into a constitutive transcriptional repressor.
    Wildonger J; Mann RS
    Development; 2005 May; 132(10):2263-72. PubMed ID: 15829516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding.
    Ptasinska A; Assi SA; Mannari D; James SR; Williamson D; Dunne J; Hoogenkamp M; Wu M; Care M; McNeill H; Cauchy P; Cullen M; Tooze RM; Tenen DG; Young BD; Cockerill PN; Westhead DR; Heidenreich O; Bonifer C
    Leukemia; 2012 Aug; 26(8):1829-41. PubMed ID: 22343733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic manipulation of AML1-ETO-induced expansion of hematopoietic precursors in a Drosophila model.
    Sinenko SA; Hung T; Moroz T; Tran QM; Sidhu S; Cheney MD; Speck NA; Banerjee U
    Blood; 2010 Nov; 116(22):4612-20. PubMed ID: 20688956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genome-wide RNA interference screen identifies a differential role of the mediator CDK8 module subunits for GATA/ RUNX-activated transcription in Drosophila.
    Gobert V; Osman D; Bras S; Augé B; Boube M; Bourbon HM; Horn T; Boutros M; Haenlin M; Waltzer L
    Mol Cell Biol; 2010 Jun; 30(11):2837-48. PubMed ID: 20368357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of AML/Runx and ETO/MTG family members during hematopoietic differentiation of embryonic stem cells.
    Okumura AJ; Peterson LF; Lo MC; Zhang DE
    Exp Hematol; 2007 Jun; 35(6):978-88. PubMed ID: 17533052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definition of a small core transcriptional circuit regulated by AML1-ETO.
    Stengel KR; Ellis JD; Spielman CL; Bomber ML; Hiebert SW
    Mol Cell; 2021 Feb; 81(3):530-545.e5. PubMed ID: 33382982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hand, an evolutionarily conserved bHLH transcription factor required for Drosophila cardiogenesis and hematopoiesis.
    Han Z; Yi P; Li X; Olson EN
    Development; 2006 Mar; 133(6):1175-82. PubMed ID: 16467358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential roles for RUNX1 and its orthologs in determining hematopoietic cell fate.
    Tracey WD; Speck NA
    Semin Cell Dev Biol; 2000 Oct; 11(5):337-42. PubMed ID: 11105897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Lozenge in
    Koranteng F; Cha N; Shin M; Shim J
    Mol Cells; 2020 Feb; 43(2):114-120. PubMed ID: 31992020
    [No Abstract]   [Full Text] [Related]  

  • 19. AML1-ETO reprograms hematopoietic cell fate by downregulating scl expression.
    Yeh JR; Munson KM; Chao YL; Peterson QP; Macrae CA; Peterson RT
    Development; 2008 Jan; 135(2):401-10. PubMed ID: 18156164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Runx transcription factors and the developmental balance between cell proliferation and differentiation.
    Coffman JA
    Cell Biol Int; 2003; 27(4):315-24. PubMed ID: 12788047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.